SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID
Open Access
- 9 January 2014
- journal article
- Published by American Society of Hematology in Blood
- Vol. 123 (2), 281-289
- https://doi.org/10.1182/blood-2013-01-476432
Abstract
A subgroup of severe combined immunodeficiencies (SCID) is characterized by lack of T and B cells and is caused by defects in genes required for T- and B-cell receptor gene rearrangement. Several of these genes are also involved in nonhomologous end joining of DNA double-strand break repair, the largest subgroup consisting of patients with T−B−NK+SCID due to DCLRE1C/ARTEMIS defects. We postulated that in patients with ARTEMIS deficiency, early and late complications following hematopoietic cell transplantation might be more prominent compared with patients with T−B−NK+SCID caused by recombination activating gene 1/2 (RAG1/2) deficiencies. We analyzed 69 patients with ARTEMIS and 76 patients with RAG1/2 deficiencies who received transplants from either HLA-identical donors without conditioning or from HLA-nonidentical donors without or with conditioning. There was no difference in survival or in the incidence or severity of acute graft-versus-host disease regardless of exposure to alkylating agents. Secondary malignancies were not observed. Immune reconstitution was comparable in both groups, however, ARTEMIS-deficient patients had a significantly higher occurrence of infections in long-term follow-up. There is a highly significant association between poor growth in ARTEMIS deficiency and use of alkylating agents. Furthermore, abnormalities in dental development and endocrine late effects were associated with alkylation therapy in ARTEMIS deficiency.Keywords
This publication has 29 references indexed in Scilit:
- DNA repair: the link between primary immunodeficiency and cancerAnnals of the New York Academy of Sciences, 2011
- Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a reviewHuman Reproduction Update, 2011
- Association of cyclophosphamide use with dental developmental defects and salivary gland dysfunction in recipients of childhood antineoplastic therapyCancer, 2010
- Radiosensitive Severe Combined Immunodeficiency DiseaseImmunology and Allergy Clinics of North America, 2010
- CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repairBone Marrow Transplantation, 2008
- Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotypeBlood, 2007
- RAG-dependent primary immunodeficienciesHuman Mutation, 2006
- Omenn syndrome due to ARTEMIS mutationsBlood, 2005
- Dental manifestations in severe combined immunodeficiency following bone marrow transplantationBone Marrow Transplantation, 2000
- Smoothing reference centile curves: The lms method and penalized likelihoodStatistics in Medicine, 1992